Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
ByHeart Formula Botulism Outbreak Has Hospitalized 31 Infants Nationwide: CDC Multi-state outbreak of botulism has led to a recall of all lots of ByHeart Infant Formula, which may still be found on some store shelves or U.S. homes. November 24, 2025 Martha Garcia Add Your Comments More than 31 infants have been hospitalized in connection with a ByHeart Infant Formula botulism outbreak, which has spread across 15 states in recent weeks. The U.S. Centers for Disease Control and Prevention (CDC) issued an infant botulism outbreak update on November 21, stating that all infants affected in the botulism outbreak have required hospitalization, with the youngest patient just 16 days old. Infant botulism is an uncommon illness that develops when Clostridium botulinum spores are ingested and begin producing toxin in a baby’s gut. Early signs often include constipation, difficulty feeding, a weak or altered cry and poor head control. Other symptoms may involve trouble swallowing and reduced facial expression. Because the condition develops gradually, symptoms may take weeks to appear. Without treatment, the illness can progress to paralysis and lead to serious breathing difficulties that may require prolonged hospitalization. In severe cases, infant botulism can be fatal. ByHeart Formula Recall LAWSUIT Did your infant become sick after eating recalled byheart formula? If your child developed botulism after consuming ByHeart infant formula, your family may be entitled to financial compensation. Lawsuits are now being pursued against ByHeart over recalls linked to bacterial contamination, manufacturing failures, and reports of severe infant harm. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ByHeart Formula Recall LAWSUIT Did your infant become sick after eating recalled byheart formula? If your child developed botulism after consuming ByHeart infant formula, your family may be entitled to financial compensation. Lawsuits are now being pursued against ByHeart over recalls linked to bacterial contamination, manufacturing failures, and reports of severe infant harm. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ByHeart Infant Formula Recall The ByHeart Infant Formula recall was first issued on November 8, after health officials connected 13 infant botulism illnesses with the contaminated ByHeart brand infant formula. Out of caution, ByHeart recalled two batches of their Whole Nutrition Infant Formula. However, following the initial recall, the outbreak continued to spread, with more infants becoming ill in the following weeks. As a result, the ByHeart Infant Formula recall has been expanded to include all lots of ByHeart Whole Nutrition Infant Formula and single serve packets that are for sale across the U.S., internationally and online. While no deaths have been reported in connection with the outbreak, at least 31 cases of infant botulism have been reported in the following 15 states, with the majority of cases having occurred in Texas: Arizona California Idaho Illinois Kentucky Maine Michigan Minnesota North Carolina New Jersey Oregon Pennsylvania Rhode Island Texas Washington Despite the risks associated with the recalled formula, the U.S. Food and Drug Administration (FDA) reports that ByHeart Infant Formula is still being found in some stores nationwide, including Walmart, Target and Kroger. In addition, previously purchased products may still remain in the homes of families nationwide, unaware of the hidden risks posed by the formula. Parents and caregivers are being advised to immediately stop using ByHeart Infant Formula. If a child has already been fed ByHeart Infant Formula and is experiencing symptoms, immediate medical attention should be sought. The investigation now includes the CDC, FDA, and the California Department of Public Health’s Infant Botulism Treatment and Prevention Program. Federal officials indicate the outbreak should not impact the national formula supply, noting that ByHeart represents roughly 1% of U.S. infant formula sales. ByHeart Botulism Outbreak Lawsuits Following the CDC announcement of the ByHeart Infant Formula botulism outbreak, multiple lawsuits have been brought nationwide. In one of the first cases, a Kentucky couple filed a lawsuit on November 18, alleging that ByHeart Infant Formula was the source of their 4-month-old daughter’s botulism illness. Days later, the manufacturers were named in a ByHeart infant formula class action lawsuit alleging ties to the botulism outbreak. The action seeks relief for families who purchased tainted batches of ByHeart Infant Formula. Sign up for more health and legal news that could affect you or your family. Tags: ByHeart, ByHeart Botulism Outbreak, ByHeart Formula Recall, ByHeart Infant Formula, ByHeart Lawsuits, Infant Botulism, Infant Botulism Outbreak, Infant Formula Image Credit: Shutterstock.com / Tada Images Written By: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. More ByHeart Recall Stories Target, Walmart and Other Retailers Reacted Too Slowly to ByHeart Infant Formula Recall: FDA December 16, 2025 ByHeart Formula Recall Lawsuit Seeks Class Action Status Over Clostridium Botulinum Contamination December 11, 2025 ByHeart Formula Lawsuit Filed Over Infant Botulism Diagnosis December 4, 2025 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: yesterday) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025) Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 2 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025) Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 5 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Target, Walmart and Other Retailers Reacted Too Slowly to ByHeart Infant Formula Recall: FDA December 16, 2025
ByHeart Formula Recall Lawsuit Seeks Class Action Status Over Clostridium Botulinum Contamination December 11, 2025
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: yesterday) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)
Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 2 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 5 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)